Advanced glycation end products (AGEs) contribute to diabetic complications primarily by:
-
A
Blocking insulin receptor binding on target tissues
-
B
Cross-linking proteins and activating RAGE receptors to cause inflammation
-
C
Directly inhibiting aldose reductase in the polyol pathway
-
D
Increasing nitric oxide production causing vasodilation